Safety, Tolerability and Performance of the NucleoCapture Extracorporeal Therapeutic Apheresis Device in the Reduction of Circulating cfDNA/NETs in Subjects With Pancreatitis
Safety, Tolerability and Performance of the NucleoCapture Extracorporeal Therapeutic Apheresis Device in the Reduction of Circulating cfDNA/NETs in Subjects With Pancreatitis
Not yet recruiting · NCT06566638 · Registry updated 2025-03-20Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Safety, Tolerability and Performance of the NucleoCapture Extracorporeal Therapeutic Apheresis Device in the Reduction of Circulating cfDNA/NETs in Subjects With Pancreatitis | Digestive System Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Shock, acute pancreatitis, multiple organ dysfunction syndrome, pancreas disorder, pancreatitis | Not yet recruiting | Not applicable | 2025-03-20 | NCT06566638 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Liverpool University Hospitals NHS Foundation Trust | 25 |
| Santersus AG | 2 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Liverpool University Hospitals NHS Foundation Trust | Liverpool | United Kingdom | 6 |